CIK 0000882095
- Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943047598
- Phone
- +1 650-574-3000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $36,996,096
- in 12 filings, $37.0M under 10b5-1 plans
Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise | +7,347 | 391,032 | ||
| 2023-12-10 | O'Day Daniel Patrick Chairman & CEO | Shares withheld for taxes | −3,341 | $79.02 | $264K | 387,691 |
| 2023-12-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise · Restricted Stock Unit | −7,347 | 110,892 | ||
| 2023-12-10 | Dickinson Andrew D Chief Financial Officer | Option exercise | +2,617 | 107,728 | ||
| 2023-12-10 | Dickinson Andrew D Chief Financial Officer | Shares withheld for taxes | −1,194 | $79.02 | $94K | 106,534 |
| 2023-12-10 | Dickinson Andrew D Chief Financial Officer | Option exercise · Restricted Stock Unit | −2,617 | 38,834 | ||
| 2023-11-10 | Dickinson Andrew D Chief Financial Officer | Option exercise | +1,912 | 105,915 | ||
| 2023-11-10 | Dickinson Andrew D Chief Financial Officer | Shares withheld for taxes | −804 | $75.92 | $61K | 105,111 |
| 2023-11-10 | Dickinson Andrew D Chief Financial Officer | Option exercise · Restricted Stock Unit | −1,912 | 41,451 | ||
| 2023-10-25 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise | +514 | 7,005 | ||
| 2023-10-25 | Telman Deborah H EVP, Corporate Affairs & GC | Shares withheld for taxes | −243 | $78.39 | $19K | 6,762 |
| 2023-10-25 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise · Restricted Stock Unit | −514 | 32,337 | ||
| 2023-10-17 | Dickinson Andrew D Chief Financial Officer | Sale 10b5-1 | −5,000 | $80.00 | $400K | 104,003 |
| 2023-09-28 | Lofton Kevin E Director | Grant or award · Phantom Stock | +31.46 | 3,194.72 | ||
| 2023-09-12 | Parsey Merdad Chief Medical Officer | Sale 10b5-1 | −1,501 | $76.99 | $116K | 70,130 |
| 2023-09-10 | Mercier Johanna Chief Commercial Officer | Option exercise | +2,730 | 90,744 | ||
| 2023-09-10 | Mercier Johanna Chief Commercial Officer | Shares withheld for taxes | −1,256 | $76.00 | $95K | 89,488 |
| 2023-09-10 | Mercier Johanna Chief Commercial Officer | Option exercise · Restricted Stock Unit | −2,730 | 42,717 | ||
| 2023-09-10 | Dickinson Andrew D Chief Financial Officer | Option exercise | +2,619 | 110,206 | ||
| 2023-09-10 | Dickinson Andrew D Chief Financial Officer | Shares withheld for taxes | −1,203 | $76.00 | $91K | 109,003 |
Page 32 of 43 · 851 trades